0000950170-24-037213.txt : 20240327
0000950170-24-037213.hdr.sgml : 20240327
20240327162009
ACCESSION NUMBER: 0000950170-24-037213
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240325
FILED AS OF DATE: 20240327
DATE AS OF CHANGE: 20240327
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thorell Marella
CENTRAL INDEX KEY: 0001826323
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37465
FILM NUMBER: 24790894
MAIL ADDRESS:
STREET 1: 1226 CHARTER LANE
CITY: AMBLER
STATE: PA
ZIP: 19002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seres Therapeutics, Inc.
CENTRAL INDEX KEY: 0001609809
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 274326290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617 945 9626
MAIL ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Seres Health, Inc.
DATE OF NAME CHANGE: 20140603
4
1
ownership.xml
4
X0508
4
2024-03-25
0001609809
Seres Therapeutics, Inc.
MCRB
0001826323
Thorell Marella
C/O SERES THERAPEUTICS, INC.
101 CAMBRIDGE PARK DRIVE
CAMBRIDGE
MA
02140
false
true
false
false
See Remarks
false
Stock Options (right to buy)
0.79
2024-03-25
4
A
false
700000
0.00
A
2034-03-24
Common Stock
700000
700000
D
The option will vest as to 25% of the shares on March 25, 2025. The remainder of the shares will vest in 12 equal quarterly installments thereafter.
EVP and Chief Financial Officer
/s//Thomas J. DesRosier, Attorney-in-Fact for Marella Thorell
2024-03-27